As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Cell Therapy Market: By Type: Autologous, Allogeneic; By Therapy: Mesenchymal Stem Cell Therapy, Fibroblast Cell Therapy, Haematopoietic Stem Cell Therapy; By Application; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Value Chain Analysis; Competitive Landscape; Industry Events and Developments

Global Cell Therapy Market Outlook

The global cell therapy market is expected to grow in the forecast period of 2021-2026 at a CAGR of 7%.

 

Increasing Use of Cell Therapies to Treat Severe COVID-19 Patients to Boost the Growth of the Cell Therapy Industry

The global market for cell therapy is  being driven by the increasing research and development (R&D) activities in the medical industry. Cell therapy is increasingly being used to treat patients with cancer, weakened immune systems, infectious diseases, and neurological disorders, which, in turn, surging its demand. Further, the COVID-19 pandemic is expected to positively impact the pharmaceutical and biotechnology-based research projects, including cell therapy.

 

Global Cell Therapy Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

As the SARS-CoV-2 virus critically damages the lungs and immune system of the infected patient, various cell therapies are increasingly being explored as a potential treatment for the novel disease. Moreover, cell therapy can substantially improve survival rates of end-stage patients with acute respiratory distress syndrome (ARSD) associated with SARS-CoV-2, which is providing further impetus to the industry growth.

 

Europe Represents a Significant Regional Market for Cell Therapy Due to the Rising R&D Activities

Europe holds a significant share of the overall cell therapy industry, with France and the United Kingdom  being some of the dominant regional markets. The increasing research and development activities in France, owing to the presence of some of the leading biotech and research institutions of cell therapy, are aiding the market growth. In addition, the French biotech institutions, with government aid, are contributing to the development of innovative cell therapies. Moreover, the introduction of various favourable government initiatives to aid research activities is invigorating the industry growth, hence contributing to the overall market growth in the European region. For instance, the United Kingdom government initiated the Human-Induced Pluripotent Stem Cells Initiative (HipSCi) to bring preclinical, clinical and pharmacological work on stem cells under one institution and increase the accessibility of induced pluripotent stem cell (iPSC) resources to identify new mechanisms.

 

Cell Therapy: Industry  Definition and Segmentation

Cell therapy refers to a medical treatment in which ailing or dysfunctional cells are replaced with healthy and functional cells. The therapy aims at reducing or curing symptoms of diseases by restoring and altering certain sets of cells or by using cells to carry a remedy through the body. These cells may either be derived from the patient (autologous cells) or a donor (allogeneic cells). The cells are cultivated outside the body before transplanting into the patient.

Based on type, the market is divided into:

  • Autologous
  • Allogeneic

On the basis of therapy, the cell therapy industry is categorised into:

  • Mesenchymal Stem Cell Therapy
  • Fibroblast Cell Therapy
  • Haematopoietic Stem Cell Therapy

Based on application, the market is segmented into:

  • Musculoskeletal
  • Malignancies
  • Cardiovascular
  • Dermatology and Wounds

The EMR report looks into the regional market of cell therapy like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.

 

Increasing Investments in Infrastructure and Technology of Cell Therapy to Augment the Market Growth

With the growth in discoveries and innovations taking place around the globe, the healthcare sector is flourishing rapidly, which, in turn, is aiding the growth of the cell therapy industry. Cell therapies are becoming an ideal choice for treatment due to their high success rate, which is expected to fuel the market growth further. Various innovative cell therapies are emerging as a promising treatment for cancer and other diseases and are supporting the overall market growth. Increasing investments in the field of cell therapy, growing technological advancements, and rising cases of diseases such as cancer and cardiac abnormalities are also driving the growth of the industry.

The rapid expansion of the cell therapy industry to enhance the accessibility and functionality of cell therapies while reducing toxicity is anticipated to propel the market growth. The development of effective treatment of solid tumours  is likely to be another breakthrough for cell-based therapies, which is expected to  positively impact the market development in the coming years. Furthermore, the increasing investments for the research and development (R&D) activities to minimise costs during the manufacturing process while eliminating the requirement of a specialised structure is estimated to invigorate the growth of the cell therapy industry. The potential for cell therapy to treat major diseases such as cancer, anaemia, and Alzheimer’s disease, among others, is projected to further strengthen the cell therapy industry in the forecast period.

 

Key Industry Players in the Global Cell Therapy Market

The report presents a detailed analysis of the following key players in the global cell therapy market, looking into their capacity, market share, and latest developments like capacity expansions, plant turnabouts and mergers and acquisitions.

  • Tego Science
  • Chiesi Farmaceutici S.p.A
  • Pharmicell Co., Ltd
  • Others

The comprehensive report looks at the micro and macro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of the Porter’s Five Forces Model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Therapy, Application, Region
Breakup by Type Autologous, Allogeneic
Breakup by Therapy Mesenchymal Stem Cell Therapy, Fibroblast Cell Therapy, Haematopoietic Stem Cell Therapy
Breakup by Application Musculoskeletal, Malignancies, Cardiovascular, Dermatology and Wounds
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Tego Science, Chiesi Farmaceutici S.p.A., Pharmicell Co., Ltd., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Cell Therapy Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Cell Therapy Historical Market (2016-2020) 
    8.3    Global Cell Therapy Market Forecast (2021-2026)
    8.4    Global Cell Therapy Market by Type
        8.4.1    Autologous
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Allogeneic
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
    8.5    Global Cell Therapy Market by Therapy
        8.5.1    Mesenchymal Stem Cell Therapy
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
        8.5.2    Fibroblast Cell Therapy
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
        8.5.3    Haematopoietic Stem Cell Therapy
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2016-2020)
            8.5.3.3    Forecast Trend (2021-2026)
    8.6    Global Cell Therapy Market by Application
        8.6.1    Musculoskeletal
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2016-2020)
            8.6.1.3    Forecast Trend (2021-2026)
        8.6.2    Malignancies
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2016-2020)
            8.6.2.3    Forecast Trend (2021-2026)
        8.6.3    Cardiovascular
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2016-2020)
            8.6.3.3    Forecast Trend (2021-2026)
        8.6.4    Dermatology and Wounds
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2016-2020)
            8.6.4.3    Forecast Trend (2021-2026)
    8.7    Global Cell Therapy Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Tego Science
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Chiesi Farmaceutici S.p.A.
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Pharmicell Co., Ltd.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Others
13    Industry Events and Developments

 

List of Figures and Tables

1.    Global Cell Therapy Market: Key Industry Highlights, 2016 and 2026
2.    Global Cell Therapy Historical Market: Breakup by Type (USD Million), 2016-2020
3.    Global Cell Therapy Market Forecast: Breakup by Type (USD Million), 2021-2026
4.    Global Cell Therapy Historical Market: Breakup by Therapy (USD Million), 2016-2020
5.    Global Cell Therapy Market Forecast: Breakup by Therapy (USD Million), 2021-2026
6.    Global Cell Therapy Historical Market: Breakup by Application (USD Million), 2016-2020
7.    Global Cell Therapy Market Forecast: Breakup by Application (USD Million), 2021-2026
8.    Global Cell Therapy Historical Market: Breakup by Region (USD Million), 2016-2020
9.    Global Cell Therapy Market Forecast: Breakup by Region (USD Million), 2021-2026
10.    North America Cell Therapy Historical Market: Breakup by Country (USD Million), 2016-2020
11.    North America Cell Therapy Market Forecast: Breakup by Country (USD Million), 2021-2026
12.    Europe Cell Therapy Historical Market: Breakup by Country (USD Million), 2016-2020
13.    Europe Cell Therapy Market Forecast: Breakup by Country (USD Million), 2021-2026
14.    Asia Pacific Cell Therapy Historical Market: Breakup by Country (USD Million), 2016-2020
15.    Asia Pacific Cell Therapy Market Forecast: Breakup by Country (USD Million), 2021-2026
16.    Latin America Cell Therapy Historical Market: Breakup by Country (USD Million), 2016-2020
17.    Latin America Cell Therapy Market Forecast: Breakup by Country (USD Million), 2021-2026
18.    Middle East and Africa Cell Therapy Historical Market: Breakup by Country (USD Million), 2016-2020
19.    Middle East and Africa Cell Therapy Market Forecast: Breakup by Country (USD Million), 2021-2026
20.    Global Cell Therapy Market Structure

Key Questions Answered in the Report

The global cell therapy market is projected to grow at a CAGR of 7% between 2021 and 2026.

The cell therapy industry is being aided by the introduction of various favourable government initiatives and the rising investment in the healthcare sector for the integration of technological advancements in biotechnological researches.

The industry is anticipated to be driven by the use of cell therapies as effective COVID-19 and cancer treatments, the rising cost-effectiveness of cell therapy, and the increasing investments in research and development (R&D) activities.

The major regions in the industry are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.

The major types of cell therapy in the market are autologous and allogeneic.

Mesenchymal stem cell therapy, fibroblast cell therapy, and hematopoietic stem cell therapy are the leading therapy segments in the cell therapy industry.

The significant application segments of cell therapy in the market are musculoskeletal, malignancies, cardiovascular, and dermatology and wounds.

They key players in the market are Tego Science, Chiesi Farmaceutici S.p.A, and Pharmicell Co., Ltd, among others.

Analyst Review

The global cell therapy market was driven by the rising use of cell therapy in the treatment of critical COVID-19 patients. Aided by the increasing investments into the development of cell therapies, the market is expected to witness a healthy growth in the forecast period of 2021-2026 growing at a CAGR of 7%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its type, cell therapy is divided into autologous and allogeneic. On the basis of therapy, the market is segmented into mesenchymal stem cell therapy, fibroblast cell therapy, and hematopoietic stem cell therapy. Based on its application, the market is categorised into musculoskeletal, malignancies, cardiovascular, and dermatology and wounds. The major regional markets for cell therapy are North America, Latin America, Europe, the Asia Pacific, and the Middle East and Africa. The key players in the above market include Tego Science, Chiesi Farmaceutici S.p.A, and Pharmicell Co., Ltd, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER